General Information of Drug (ID: DMW6IUB)

Drug Name
AZD-8309 Drug Info
Indication
Disease Entry ICD 11 Status REF
Chronic obstructive pulmonary disease CA22 Discontinued in Phase 1 [1]
Rheumatoid arthritis FA20 Discontinued in Phase 1 [1]
Cross-matching ID
PubChem CID
12073810
TTD Drug ID
DMW6IUB

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Drug(s) Targeting Chemokine receptor (CHR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
AZD-3778 DM4K085 Asthma CA23 Discontinued in Phase 2 [3]
AZD-4750 DMQ2VYT Multiple sclerosis 8A40 Discontinued in Phase 1 [4]
AZD-7140 DMX63W1 Chronic obstructive pulmonary disease CA22 Discontinued in Phase 1 [5]
AZD-0275 DMJH7IX Chronic obstructive pulmonary disease CA22 Terminated [6]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Chemokine receptor (CHR) TTQR8Z6 NOUNIPROTAC Modulator [2]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017125)
2 CXCR2: From Bench to Bedside. Front Immunol. 2012; 3: 263.
3 New Drugs and Targets for Asthma and COPD. Trevor T. Hansel, Peter J. Barnes. 2010. Page(304).
4 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018778)
5 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017126)
6 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019127)